Bidisomide

比地索胺

Report date: 2023/04/25 15:42:59
NME

Base Information

Drug NameBidisomide
Drug Alias NameSC-40230
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type I alpha subunit blockers
TargetsSodium channel protein type I alpha subunit
Therapy Area/IndicationsArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksKEGG